Psoriasis  >>  MK 0873  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK 0873 / Merck (MSD)
NCT01140061: Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)

Completed
1
42
NA
MK-0873 Patch, MK-0873 Cream, Placebo Patch, Placebo Cream, Plain patch
Merck Sharp & Dohme LLC
Plaque Psoriasis
03/11
03/11
NCT01235728: A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

Completed
1
24
US
MK-0873 2% Cream, MK-0873 vehicle (placebo) Cream, Calcitriol Cream
Merck Sharp & Dohme LLC
Psoriasis, Plaque Psoriasis
04/11
04/11

Download Options